Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Handley

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
Science (New York, N.Y.)|January 12, 2023
ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathyDong-Oh Seo, David O'Donnell, Nimansha Jain, et al.
Immunity|January 15, 2017
Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African WomenChristina Gosmann, Melis N Anahtar, Scott A Handley, et al.
Cell Host & Microbe|October 5, 2021
Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunityRita E Chen, Brittany K Smith, John M Errico, et al.
Nature Communications|February 5, 2024
HIV-associated gut microbial alterations are dependent on host and geographic contextMuntsa Rocafort, David B Gootenberg, Jesús M Luévano, et al.
Cell Host & Microbe|March 11, 2016
Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency SyndromeCynthia L Monaco, David B Gootenberg, Guoyan Zhao, et al.
Cell|October 16, 2012
Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric viromeScott A Handley, Larissa B Thackray, Guoyan Zhao, et al.
Plos Medicine|February 20, 2024
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trialFred C Semitala, Jillian L Kadota, Allan Musinguzi, et al.
PLOS Global Public Health|October 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
Med (New York, N.Y.)|November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
Science (New York, N.Y.)|January 12, 2023
ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathyDong-Oh Seo, David O'Donnell, Nimansha Jain, et al.
Immunity|January 15, 2017
Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African WomenChristina Gosmann, Melis N Anahtar, Scott A Handley, et al.
Cell Host & Microbe|October 5, 2021
Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunityRita E Chen, Brittany K Smith, John M Errico, et al.
Nature Communications|February 5, 2024
HIV-associated gut microbial alterations are dependent on host and geographic contextMuntsa Rocafort, David B Gootenberg, Jesús M Luévano, et al.
Cell Host & Microbe|March 11, 2016
Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency SyndromeCynthia L Monaco, David B Gootenberg, Guoyan Zhao, et al.
Cell|October 16, 2012
Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric viromeScott A Handley, Larissa B Thackray, Guoyan Zhao, et al.
Plos Medicine|February 20, 2024
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trialFred C Semitala, Jillian L Kadota, Allan Musinguzi, et al.
PLOS Global Public Health|October 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options TrialAllan Musinguzi, Joan R Kasidi, Jillian L Kadota, et al.
Med (New York, N.Y.)|November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Pageof 34